Pathophysiology of airway colonization in critically ill COPD patient

Saad Nseir1, Florence Ader, Rémy Lubret

  • 1Univ. Lille Nord de France, F-59000 Lille, France. s-nseir@chru-lille.fr

Current Drug Targets
|January 4, 2011
PubMed

Insights

Mechanical ventilation in intensive care units (ICUs) increases lower respiratory tract colonization (LRTC) risk in patients with chronic obstructive pulmonary disease (COPD). Preventive measures like noninvasive ventilation (NIV) and specific tube types can reduce LRTC and ventilator-associated pneumonia.

Area of Science:

  • Critical Care Medicine
  • Pulmonology
  • Infectious Diseases

Background:

  • Mechanical ventilation via tracheal tube in ICUs is common for severe COPD exacerbations, despite reduced intubation rates with noninvasive ventilation (NIV).
  • Intubation significantly elevates the risk of lower respiratory tract colonization (LRTC) in ICU patients, particularly those with COPD.
  • Factors like oral/gastric colonization, aspiration, tracheal tube biofilms, and COPD-related immune alterations exacerbate LRTC risk.

Purpose of the Study:

  • To review risk factors for LRTC in intubated ICU patients with COPD.
  • To discuss preventive strategies for LRTC in this vulnerable population.
  • To highlight the link between LRTC and ventilator-associated pneumonia (VAP) in COPD patients.

Main Methods:

  • Literature review of risk factors for LRTC in intubated COPD patients.
  • Analysis of microorganisms commonly isolated from intubated COPD patients.
  • Evaluation of preventive measures against LRTC and VAP.

Main Results:

  • LRTC incidence in intubated patients ranges from 22-95%.
  • Pseudomonas aeruginosa is a frequent isolate by day 3 post-intubation.
  • LRTC is a significant predictor of VAP, increasing mortality and morbidity.

Conclusions:

  • Noninvasive ventilation (NIV) reduces intubation needs and duration of invasive ventilation.
  • Preventive strategies including semirecumbent position, subglottic aspiration, and specialized tracheal tubes may reduce LRTC.
  • Further research is needed to confirm the impact of LRTC prevention on COPD patient outcomes in the ICU.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...